I am a
Home I AM A Search Login

Papers of the Week


Papers: 5 Jun 2021 - 11 Jun 2021


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2021 May


Headache


61


5

Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review.

Authors

Srouji R, Schenkel SR, Forbes P, Cahill JE
Headache. 2021 May; 61(5):777-789.
PMID: 34105158.

Abstract

Headaches are a common symptom in children. Children with refractory headaches may be admitted for inpatient treatment with intravenous dihydroergotamine mesylate (DHE). However, very few studies have characterized these patients and their treatment outcomes using validated, self-reported, pain scales.